NP / PA
Amarillo Pediatric Clinic, PLLC
Amarillo Pediatric Clinic, PLLC was paid $4.13M by Medicaid between Oct 2020 and Dec 2024, across 47 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoAMARILLO PEDIATRIC CLINIC, PLLC
AMARILLO, TX 79106
AMARILLO, TX 79106
33aNPI1164892956assigned 10/06/2015
33bProvider typeNurse Practitioner
28Total paid$4.13M
24GClaims180,244
24DCodes billed47
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Texas
Rank by total paid#4 of 142
Median peer was paid$25K
This provider vs. median164×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 5,272 | $117K | |
| 2021 | 49,218 | $1.07M | |
| 2022 | 48,069 | $1.05M | |
| 2023 | 41,882 | $976K | |
| 2024incomplete | 35,803 | $911K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 18,707 | 17,014 | $833K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 19,705 | 17,756 | $621K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 6,754 | 6,545 | $497K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.5% | 5,478 | 5,080 | $394K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.4% | 3,352 | 3,261 | $263K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.0% | 18,973 | 17,596 | $247K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.0% | 19,251 | 9,034 | $246K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.9% | 23,545 | 9,710 | $242K |
| 99429 | 3.7% | 5,325 | 5,219 | $154K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.0% | 3,111 | 2,866 | $124K |
| 87428 | 2.8% | 4,774 | 4,325 | $114K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 10,909 | 8,487 | $81K |
35 more codes
| 92558 | 1.5% | 9,357 | $60K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 713 | $60K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 588 | $46K |
| 90461 | <1% | 7,765 | $40K | |
| 87807 | <1% | 3,820 | $40K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,087 | $34K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 278 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 569 | $6K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 72 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 428 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 157 | $3K |
| 96160 | <1% | 1,194 | $1K | |
| 99382 | <1% | 12 | $953.32 | |
| 87634 | <1% | 13 | $766.61 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $184.38 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $149.60 |
| 95117 | <1% | 16 | $119.84 | |
| 81002 | <1% | 44 | $119.73 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $10.50 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $1.20 |
| 90671 | <1% | 663 | $0.20 | |
| 90677 | <1% | 753 | $0.12 | |
| 90686 | <1% | 3,025 | $0.02 | |
| 90744 | 0% | 666 | $0.00 | |
| 90647 | 0% | 837 | $0.00 | |
| 90698 | 0% | 2,948 | $0.00 | |
| 90723 | 0% | 478 | $0.00 | |
| 90651 | 0% | 13 | $0.00 | |
| 90381 | 0% | 21 | $0.00 | |
| 90696 | 0% | 48 | $0.00 | |
| 90670 | 0% | 2,425 | $0.00 | |
| 90633 | 0% | 993 | $0.00 | |
| 90710 | 0% | 657 | $0.00 | |
| 90681 | 0% | 652 | $0.00 | |
| 90734 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEATHERS, ERICA (MANAGING PARTNER)